| 17alpha-ethynylestradiol | decreases expression | ISO | RGD:733927 | 6480464 | Ethinyl Estradiol results in decreased expression of VLDLR mRNA | CTD | PMID:17555576 |
| 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of VLDLR mRNA | CTD | PMID:15901920 PMID:12075121 |
| 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of VLDLR mRNA | CTD | PMID:12075121 PMID:15901920 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:733926 | 6480464 | Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of VLDLR mRNA] | CTD | PMID:11007951 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:733927 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of VLDLR mRNA | CTD | PMID:15034205 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:733927 | 6480464 | AHR protein inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of VLDLR mRNA] | CTD | PMID:15034205 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:733927 | 6480464 | Tetrachlorodibenzodioxin affects the expression of VLDLR mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:733927 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of VLDLR mRNA | CTD | PMID:16120747 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:733927 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of VLDLR mRNA | CTD | PMID:16960034 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:733927 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of VLDLR mRNA | CTD | PMID:19465110 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:733927 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of VLDLR mRNA | CTD | PMID:19933214 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:733927 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of VLDLR mRNA | CTD | PMID:19465110 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:733926 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of VLDLR mRNA | CTD | PMID:11007951 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:733927 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of VLDLR mRNA | CTD | PMID:19465110 more ... |
| 2-methoxyethanol | increases expression | EXP | | 6480464 | methyl cellosolve results in increased expression of VLDLR mRNA | CTD | PMID:19643169 |
| 4,4'-diaminodiphenylmethane | affects expression | ISO | RGD:733927 | 6480464 | 4,4'-diaminodiphenylmethane affects the expression of VLDLR mRNA | CTD | PMID:18648102 |
| 8-bromo-3',5'-cyclic AMP | decreases expression | ISO | RGD:733926 | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of VLDLR mRNA | CTD | PMID:22079614 |
| all-trans-retinoic acid | increases expression | ISO | RGD:733926 | 6480464 | Tretinoin results in increased expression of VLDLR mRNA | CTD | PMID:21934132 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of VLDLR mRNA | CTD | PMID:16483693 |
| ampicillin | decreases expression | ISO | RGD:733926 | 6480464 | Ampicillin results in decreased expression of VLDLR mRNA | CTD | PMID:21632981 |
| arsenite(3-) | affects expression | ISO | RGD:733926 | 6480464 | arsenite affects the expression of VLDLR mRNA | CTD | PMID:22959463 |
| benzo[a]pyrene | decreases expression | ISO | RGD:733926 | 6480464 | Benzo(a)pyrene results in decreased expression of VLDLR mRNA | CTD | PMID:20106945 |
| benzo[a]pyrene | decreases expression | ISO | RGD:733927 | 6480464 | Benzo(a)pyrene results in decreased expression of VLDLR mRNA | CTD | PMID:15034205 PMID:22228805 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:733927 | 6480464 | AHR protein inhibits the reaction [Benzo(a)pyrene results in decreased expression of VLDLR mRNA] | CTD | PMID:15034205 |
| benzo[a]pyrene | decreases expression | ISO | RGD:733927 | 6480464 | Benzo(a)pyrene results in decreased expression of VLDLR mRNA | CTD | PMID:22228805 |
| benzo[a]pyrene | decreases expression | ISO | RGD:733926 | 6480464 | Benzo(a)pyrene results in decreased expression of VLDLR mRNA | CTD | PMID:20106945 PMID:21632981 |
| benzo[a]pyrene | increases expression | ISO | RGD:733927 | 6480464 | Benzo(a)pyrene results in increased expression of VLDLR mRNA | CTD | PMID:19770486 |
| bilirubin | decreases expression | ISO | RGD:733926 | 6480464 | Bilirubin results in decreased expression of VLDLR mRNA | CTD | PMID:20196124 |
| bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of VLDLR mRNA | CTD | PMID:12075121 |
| carmustine | affects response to substance | ISO | RGD:733926 | 6480464 | VLDLR mRNA affects the susceptibility to Carmustine | CTD | PMID:16365179 |
| choline | multiple interactions | ISO | RGD:733927 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of VLDLR mRNA | CTD | PMID:20938992 |
| cisplatin | decreases expression | EXP | | 6480464 | Cisplatin results in decreased expression of VLDLR mRNA | CTD | PMID:22023808 |
| clofibrate | increases expression | ISO | RGD:733927 | 6480464 | Clofibrate results in increased expression of VLDLR mRNA | CTD | PMID:17585979 |
| cobalt atom | multiple interactions | ISO | RGD:733926 | 6480464 | [tungsten carbide binds to Cobalt] which results in increased expression of VLDLR mRNA | CTD | PMID:20105288 |
| cobalt dichloride | increases expression | ISO | RGD:733926 | 6480464 | cobaltous chloride results in increased expression of VLDLR mRNA | CTD | PMID:20105288 |
| cobalt dichloride | increases expression | ISO | RGD:733926 | 6480464 | cobaltous chloride results in increased expression of VLDLR mRNA | CTD | PMID:19376846 PMID:20105288 |
| cobalt dichloride | increases expression | ISO | RGD:733926 | 6480464 | cobaltous chloride results in increased expression of VLDLR mRNA | CTD | PMID:20105288 PMID:19376846 |
| copper atom | multiple interactions | ISO | RGD:733926 | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of VLDLR mRNA | CTD | PMID:20971185 |
| copper(0) | multiple interactions | ISO | RGD:733926 | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of VLDLR mRNA | CTD | PMID:20971185 |
| copper(2+) sulfate | increases expression | ISO | RGD:733926 | 6480464 | Copper Sulfate results in increased expression of VLDLR mRNA | CTD | PMID:19549813 |
| cycloheximide | multiple interactions | ISO | RGD:733926 | 6480464 | Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of VLDLR mRNA] | CTD | PMID:11007951 |
| cyclosporin A | affects expression | ISO | RGD:733926 | 6480464 | Cyclosporine affects the expression of VLDLR mRNA | CTD | PMID:20106945 |
| cyclosporin A | increases expression | ISO | RGD:733926 | 6480464 | Cyclosporine results in increased expression of VLDLR mRNA | CTD | PMID:21632981 PMID:22147139 |
| cyclosporin A | increases expression | ISO | RGD:733926 | 6480464 | Cyclosporine results in increased expression of VLDLR mRNA | CTD | PMID:22147139 |
| dasatinib (anhydrous) | increases expression | ISO | RGD:733926 | 6480464 | dasatinib results in increased expression of VLDLR mRNA | CTD | PMID:20579391 |
| diarsenic trioxide | increases expression | ISO | RGD:733926 | 6480464 | arsenic trioxide results in increased expression of VLDLR mRNA | CTD | PMID:20458559 |
| dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of VLDLR mRNA | CTD | PMID:21266533 |
| dioxygen | increases expression | ISO | RGD:733927 | 6480464 | Oxygen deficiency results in increased expression of VLDLR mRNA | CTD | PMID:20880076 |
| diuron | increases expression | EXP | | 6480464 | Diuron results in increased expression of VLDLR mRNA | CTD | PMID:21551480 |
| ethanol | decreases expression | ISO | RGD:733927 | 6480464 | Ethanol results in decreased expression of VLDLR mRNA | CTD | PMID:22173916 |
| ethanol | increases expression | ISO | RGD:733927 | 6480464 | Ethanol results in increased expression of VLDLR mRNA | CTD | PMID:19167417 |
| ethanol | multiple interactions | ISO | RGD:733927 | 6480464 | rosiglitazone inhibits the reaction [Ethanol results in decreased expression of VLDLR mRNA] | CTD | PMID:22173916 |
| fluoxetine | increases expression | EXP | | 6480464 | Fluoxetine results in increased expression of VLDLR protein | CTD | PMID:19359144 |
| flutamide | increases expression | ISO | RGD:733927 | 6480464 | Flutamide analog results in increased expression of VLDLR mRNA; more ... | CTD | PMID:17702527 |
| folic acid | multiple interactions | ISO | RGD:733927 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of VLDLR mRNA | CTD | PMID:20938992 |
| fonofos | increases methylation | ISO | RGD:733926 | 6480464 | Fonofos results in increased methylation of VLDLR promoter | CTD | PMID:22847954 |
| geldanamycin | multiple interactions | EXP | | 6480464 | geldanamycin inhibits the reaction [IL1B protein results in decreased expression of VLDLR protein] | CTD | PMID:15808840 |
| genistein | increases expression | EXP | | 6480464 | Genistein results in increased expression of VLDLR mRNA | CTD | PMID:12075121 |
| haloperidol | increases expression | EXP | | 6480464 | Haloperidol results in increased expression of VLDLR protein | CTD | PMID:19359144 |
| herbimycin | multiple interactions | EXP | | 6480464 | herbimycin inhibits the reaction [IL1B protein results in decreased expression of VLDLR protein] | CTD | PMID:15808840 |
| hydrogen peroxide | affects expression | ISO | RGD:733926 | 6480464 | Hydrogen Peroxide affects the expression of VLDLR mRNA | CTD | PMID:20044591 |
| L-methionine | multiple interactions | ISO | RGD:733927 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of VLDLR mRNA | CTD | PMID:20938992 |
| methotrexate | affects expression | ISO | RGD:733927 | 6480464 | Methotrexate affects the expression of VLDLR mRNA | CTD | PMID:18502557 |
| nickel dichloride | increases expression | ISO | RGD:733926 | 6480464 | nickel chloride results in increased expression of VLDLR mRNA | CTD | PMID:17312168 |
| olanzapine | increases expression | EXP | | 6480464 | olanzapine results in increased expression of VLDLR protein | CTD | PMID:19359144 |
| paracetamol | affects expression | ISO | RGD:733927 | 6480464 | Acetaminophen affects the expression of VLDLR mRNA | CTD | PMID:15030884 PMID:17562736 |
| paracetamol | affects expression | ISO | RGD:733927 | 6480464 | Acetaminophen affects the expression of VLDLR mRNA | CTD | PMID:17562736 PMID:15030884 |
| parathion | increases methylation | ISO | RGD:733926 | 6480464 | Parathion results in increased methylation of VLDLR promoter | CTD | PMID:22847954 |
| perfluorooctanoic acid | increases expression | ISO | RGD:733927 | 6480464 | perfluorooctanoic acid results in increased expression of VLDLR mRNA | CTD | PMID:17681415 |
| perfluorooctanoic acid | increases expression | EXP | | 6480464 | perfluorooctanoic acid results in increased expression of VLDLR mRNA | CTD | PMID:19162173 |
| phenobarbital | multiple interactions | ISO | RGD:733927 | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in increased expression of VLDLR mRNA] | CTD | PMID:19482888 |
| phenobarbital | affects expression | ISO | RGD:733927 | 6480464 | Phenobarbital affects the expression of VLDLR mRNA | CTD | PMID:19136022 PMID:23091169 |
| phenobarbital | increases expression | ISO | RGD:733927 | 6480464 | Phenobarbital results in increased expression of VLDLR mRNA | CTD | PMID:19482888 |
| phenobarbital | affects expression | ISO | RGD:733927 | 6480464 | Phenobarbital affects the expression of VLDLR mRNA | CTD | PMID:19136022 |
| pioglitazone | increases expression | ISO | RGD:733927 | 6480464 | pioglitazone results in increased expression of VLDLR mRNA | CTD | PMID:19706614 |
| pirinixic acid | multiple interactions | ISO | RGD:733926 | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of VLDLR mRNA | CTD | PMID:19710929 |
| pirinixic acid | increases expression | ISO | RGD:733927 | 6480464 | pirinixic acid results in increased expression of VLDLR mRNA | CTD | PMID:17426115 more ... |
| pirinixic acid | increases expression | ISO | RGD:733927 | 6480464 | pirinixic acid results in increased expression of VLDLR mRNA | CTD | PMID:17426115 more ... |
| pirinixic acid | increases expression | ISO | RGD:733927 | 6480464 | pirinixic acid results in increased expression of VLDLR mRNA | CTD | PMID:18301758 more ... |
| pirinixic acid | increases expression | ISO | RGD:733927 | 6480464 | pirinixic acid results in increased expression of VLDLR mRNA | CTD | PMID:20813756 more ... |
| pirinixic acid | increases expression | ISO | RGD:733927 | 6480464 | pirinixic acid results in increased expression of VLDLR mRNA | CTD | PMID:17950772 more ... |
| pirinixic acid | increases expression | ISO | RGD:733927 | 6480464 | pirinixic acid results in increased expression of VLDLR mRNA | CTD | PMID:18301758 more ... |
| pirinixic acid | multiple interactions | ISO | RGD:733927 | 6480464 | PPARA protein promotes the reaction [pirinixic acid results in increased expression of VLDLR mRNA] | CTD | PMID:17950772 |
| pirinixic acid | multiple interactions | ISO | RGD:733927 | 6480464 | [pirinixic acid co-treated with PPARA] results in increased expression of VLDLR mRNA | CTD | PMID:20813756 |
| pirinixic acid | affects expression | ISO | RGD:733927 | 6480464 | pirinixic acid affects the expression of VLDLR mRNA | CTD | PMID:19136022 |
| quercetin | decreases expression | ISO | RGD:733926 | 6480464 | Quercetin results in decreased expression of VLDLR mRNA | CTD | PMID:21632981 |
| radicicol | multiple interactions | EXP | | 6480464 | monorden inhibits the reaction [IL1B protein results in decreased expression of VLDLR protein] | CTD | PMID:15808840 |
| rosiglitazone | multiple interactions | ISO | RGD:733927 | 6480464 | rosiglitazone inhibits the reaction [Ethanol results in decreased expression of VLDLR mRNA] | CTD | PMID:22173916 |
| rosiglitazone | increases expression | EXP | | 6480464 | rosiglitazone results in increased expression of VLDLR mRNA | CTD | PMID:21515302 |
| rosiglitazone | increases expression | ISO | RGD:733927 | 6480464 | rosiglitazone results in increased expression of VLDLR mRNA; more ... | CTD | PMID:19706614 |
| rotenone | increases expression | ISO | RGD:733927 | 6480464 | Rotenone results in increased expression of VLDLR mRNA | CTD | PMID:17702527 |
| tamoxifen | affects expression | ISO | RGD:733927 | 6480464 | Tamoxifen affects the expression of VLDLR mRNA | CTD | PMID:17555576 |
| temozolomide | affects response to substance | ISO | RGD:733926 | 6480464 | VLDLR mRNA affects the susceptibility to temozolomide | CTD | PMID:16365179 |
| terbufos | increases methylation | ISO | RGD:733926 | 6480464 | terbufos results in increased methylation of VLDLR promoter | CTD | PMID:22847954 |
| testosterone | decreases expression | ISO | RGD:733927 | 6480464 | Testosterone results in decreased expression of VLDLR mRNA | CTD | PMID:20844152 PMID:20403060 |
| testosterone | decreases expression | ISO | RGD:733927 | 6480464 | Testosterone results in decreased expression of VLDLR mRNA | CTD | PMID:20403060 PMID:20844152 |
| testosterone | increases expression | ISO | RGD:733927 | 6480464 | Testosterone results in increased expression of VLDLR mRNA | CTD | PMID:20403060 |
| tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of VLDLR protein | CTD | PMID:12629582 |
| trimellitic anhydride | decreases expression | ISO | RGD:733927 | 6480464 | trimellitic anhydride results in decreased expression of VLDLR mRNA | CTD | PMID:19042947 |
| troglitazone | increases expression | EXP | | 6480464 | troglitazone results in increased expression of VLDLR mRNA | CTD | PMID:21515302 |
| valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of VLDLR mRNA; more ... | CTD | PMID:19359144 |
| valproic acid | increases expression | ISO | RGD:733927 | 6480464 | Valproic Acid results in increased expression of VLDLR mRNA | CTD | PMID:22045034 |
| vancomycin | increases expression | ISO | RGD:733927 | 6480464 | Vancomycin results in increased expression of VLDLR mRNA | CTD | PMID:18930951 |